FIELD: chemistry of peptides. SUBSTANCE: products: derivatives of peptides of the formula (I): where R1 is hydrogen, (lower)-alkyl; R2 is (lower)-alkyl, halogen; R3 is hydrogen, (lower)-alkyl, halogen; R4 is (lower)- -alkyl; R5 is aryl, (lower)-alkyl; R6 is NH2 or optionally substituted hydroxyl-group, or their pharmaceutically acceptable salts. Compounds of the formula (I) are synthesized by interaction of compound (II): or its amino-group reactive derivative and compound (III): , or its amino-group reactive derivative. Invention relates to also pharmaceutical composition containing an effective amount of peptide derivative of the formula (I) as an active component or its pharmaceutically acceptable salt, method of inhibition of tachykinin effect by effect on tachykinin receptors - derivative of peptide of the formula (I) at effective amount. The synthesized compounds can be used for treatment of patients with respiratory diseases (asthma, bronchitis, rhinitis and others), ophthalmic diseases, skin diseases (contact dermatitis, diffuse neurodermitis, nettle rash), inflammatory diseases (rheumatic arthritis, osteoarthritis), pains (migraine, headache, tooth, cancer, back pains and others) in humans and animals. Synthesized compounds show antagonism with respect to tachykinin. EFFECT: improved method of synthesis, enhanced effectiveness of compounds synthesized. 6 cl, 4 dwg, 1 tbl, 28 ex
Title | Year | Author | Number |
---|---|---|---|
CYCLOPEPTIDE OR ITS PHARMACEUTICALLY ACCEPTABLE SALT, METHODS OF SYNTHESIS AND PHARMACEUTICAL COMPOSITION | 1991 |
|
RU2108342C1 |
PYRAZOLE DERIVATIVES OR THEIR PHARMACEUTICALLY ACCEPTABLE SALTS | 1993 |
|
RU2128172C1 |
CEPHEM COMPOUNDS AND THEIR PHARMACEUTICALLY ACCEPTABLE SALTS | 1992 |
|
RU2081874C1 |
ETHANOLAMINE DERIVATIVES, METHOD OF THEIR SYNTHESIS, PHARMACEUTICAL COMPOSITION, METHOD OF TREATMENT | 1993 |
|
RU2125983C1 |
DERIVATIVES OF N-(3-PIPERIDINYLCARBONYL)-BETA-ALANINE AS ANTAGONISTS OF PLATELET ACTIVATION FACTOR, METHOD OF SYNTHESIS, PHARMACEUTICAL COMPOSITION AND METHOD OF TREATMENT | 1994 |
|
RU2161155C2 |
HETEROCYCLIC COMPOUNDS OR PHARMACEUTICALLY ACCEPTABLE SALT THEREOF AND INTERMEDIATE COMPOUNDS | 1994 |
|
RU2176640C2 |
POLYPEPTIDE COMPOUND, METHOD OF ITS SYNTHESIS AND PHARMACEUTICAL COMPOSITION | 1995 |
|
RU2165423C2 |
POLYPEPTIDE COMPOUNDS, METHOD OF THEIR SYNTHESIS, PHARMACEUTICAL COMPOSITION, METHOD OF PROPHYLAXIS AND/OR THERAPEUTIC TREATMENT | 1994 |
|
RU2164230C2 |
METHOD OF SYNTHESIS OF PYRAZOLE DERIVATIVES OR THEIR PHARMACEUTICALLY ACCEPTABLE SALTS | 1990 |
|
RU2021990C1 |
METHOD OF SYNTHESIS OF ALKANESULFONANILIDE DERIVATIVES OR THEIRS PHARMACEUTICALLY ACCEPTABLE SALTS | 1988 |
|
RU2012557C1 |
Authors
Dates
1998-10-10—Published
1993-04-09—Filed